Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ESSA Pharma Inc. | Chief Executive Officer, Director | Common Shares | 65.7K | $657K | $10.01 | Dec 14, 2023 | Direct |
ESSA Pharma Inc. | Chief Executive Officer, Director | Options | 350K | Mar 25, 2024 | Direct | ||
CTI BIOPHARMA CORP | Director | Stock Option (Right to Buy) | 0 | Jun 26, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
EPIX | ESSA Pharma Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 28, 2024 | Chief Executive Officer, Director |
EPIX | ESSA Pharma Inc. | Dec 14, 2023 | 1 | $21.2K | 4 | Dec 18, 2023 | Chief Executive Officer, Director |
CTIC | CTI BIOPHARMA CORP | Jun 26, 2023 | 7 | $0 | 4 | Jun 26, 2023 | Director |
CTIC | CTI BIOPHARMA CORP | Apr 5, 2023 | 1 | $0 | 4 | Apr 7, 2023 | Director |
EPIX | ESSA Pharma Inc. | Dec 22, 2022 | 2 | $59K | 4 | Jan 5, 2023 | Chief Executive Officer, Director |
EPIX | ESSA Pharma Inc. | Jun 30, 2022 | 1 | $14.5K | 4 | Jul 5, 2022 | Chief Executive Officer, Director |
EPIX | ESSA Pharma Inc. | Jun 29, 2022 | 1 | $0 | 4 | Nov 1, 2022 | Chief Executive Officer, Director |
CTIC | CTI BIOPHARMA CORP | Mar 9, 2022 | 1 | $0 | 4 | Mar 11, 2022 | Director |